Enzymatica partners with Unibet Rose Rockets to put ColdZyme in the Giro d’Italia race routine
ColdZyme will be used by one of professional cycling’s most talked-about teams during training and racing - placing the throat spray in a setting where staying healthy is critical to performance.
Enzymatica AB is pleased to announce a partnership with UCI ProTeam Unibet Rose Rockets, under which the team will be supplied with ColdZyme to support their athletes through the 2026 race season, including their debut at the Giro d'Italia.
The collaboration reflects a shared understanding of the respiratory challenges facing elite cyclists. Training load, shared environments, and the physiological demands of Grand Tour racing leave athletes particularly vulnerable to upper respiratory tract infections - precisely the conditions ColdZyme is designed to address. The product creates a protective barrier in the throat and is clinically documented to reduce the duration and severity of colds.
"Keeping our riders healthy is one of the most important factors in achieving consistent performance, especially during a grand tour such as the Giro d’Italia. By partnering with Coldzyme, we can further strengthen our preventive health approach and provide our athletes with additional support during periods of increased exposure to respiratory viruses, particularly during travel and competition. Not suprsingly, all 8 riders finished our first grand tour without major illness", says Jelle Posthuma Team Doctor, Unibet Rose Rockets.
"Cyclists at the highest level are operating on fine margins," said Charlotte Hodgkins-Byrne, Director of Partnerships, Enzymatica. "A cold at the wrong moment in a three-week race can end a campaign. ColdZyme fits naturally into a performance routine, and we're looking forward to supporting the Rockets through what is shaping up to be a landmark season."
For more information, please contact:
Sana Alajmovic, CEO, Enzymatica AB
Phone: +46 723893396 | E-mail: [email protected]
About Unibet Rose - a fast-growing cycling platform
Unibet Rose Rockets was founded in 2023 by former professional cyclist and YouTube creator Bas Tietema. In 2026, the team received a wildcard entry to the Giro d’Italia - its first Grand Tour. The team has more than 210,000 Instagram followers and around 250,000 subscribers on the Tour de Tietema YouTube channel, where fans follow life behind the scenes during races, training camps and travel. During the Giro d’Italia, ColdZyme will be integrated into the team’s race environment and daily routines, with the partnership featured naturally in documentary-style and social media content. https://rocketscycling.com
Facts ColdZyme®
ColdZyme® is a mouth spray used for colds and cold-like symptoms. The spray is applied to the mouth and throat and forms a protective barrier that captures viruses, making it more difficult for them to infect the body’s cells and multiply. When used early, at the first signs of a cold, ColdZyme® may help shorten the duration of the cold and reduce symptom severity. ColdZyme® is a medical device certified under the EU Medical Device Regulation (MDR, Class III). Read more at www.coldzyme.se
About. Enzymatica
Enzymatica AB (publ) is a Swedish life science company that develops scientifically backed solutions for the treatment and relief of infections and related symptoms, based on a unique barrier technology platform. Enzymatica is headquartered in Lund, Sweden, and is listed on Nasdaq First North Growth Market. Certified Adviser is DNB Carnegie Investment Bank AB (publ). For more information, visit www.enzymatica.se
